The protein corona effect for targeted drug delivery

Bioinspired, Biomimetic and Nanobiomaterials

Volumn 2, Issue 1, 2013, Pages 54-57

  Caracciolo, Giulio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Biomedicine; Cell surface interaction; Nanobiomaterial

Indexed keywords

DRUG DELIVERY; LIGANDS; NANOPARTICLES; SURFACE PROPERTIES; TISSUE;

BIOMEDICINE; CELL INTERNALIZATION; CELL-SURFACE INTERACTIONS; IN-DEPTH UNDERSTANDING; NANOBIOMATERIAL; NANOPARTICLE SURFACE; SURFACE FUNCTIONALIZATION; TARGETED DRUG DELIVERY;

PROTEINS;

EID: 84930190744     PISSN: 20459858     EISSN: 20459866     Source Type: Journal    
DOI: 10.1680/bbn.12.00027     Document Type: Article

References (33)

1. Devalapally, H.; Chakilam, A.; Amiji, M. M. Role of nanotechnology in pharmaceutical product development. Journal of Pharmacobio-Dynamics 2007, 96, 2547-2565.
2. Chrastina, A.; Massey, K. A; Schnitzer, J. E. Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2011, 3, 421-437.
3. Yan, Y.; Such, G. K.; Johnston, A. P. R.; Best, J. P.; Caruso, F. Engineering particles for therapeutic delivery: prospects and challenges. Action (National Fund for Research into Crippling Diseases) 2012, 6, 3663-3669.
4. Wang, A. Z.; Langer, R.; Farokhzad, O. C. Nanoparticle delivery of cancer drugs. Annual Review of Medicine 2012, 63, 185-198.
5. Khanna, V. K. Targeted delivery of nanomedicines. ISRN Pharmacology 2012, 2012, 1-9.
6. Maedaa, H.; Wua, J.; Sawaa, T.; Matsumurab, Y; Horic, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of Controlled Release 2000, 65, 271-284.
7. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Research 1986, 46, 6387-6392.
8. Maeda, H.; Matsumura, Y. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. Advanced Drug Delivery Reviews 2011, 63, 129-130.
9. Choia, C. H. J.; Alabia, C. A.; Websterb, P.; Davis, M. E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proceedings of the National Academy of Science of the United States of America 2010, 19, 1235-1240.
10. Yu, B.; Tai, H. C.; Xue, W.; Lee, L. J.; Lee, R. J. Receptortargeted nanocarriers for therapeutic delivery to cancer. Molecular Membrane Biology 2010, 27, 286-298.
11. Debbage, P. Targeted drugs and nanomedicine: present and future. Current Pharmaceutical Design 2009, 15, 153-172.
12. Chattopadhyay, N.; Fonge, H.; Cai, Z.; Scollard, D.; Lechtman, E.; Done, S. J.; Pignol, J.-P.; Reilly, R. M. Role of antibodymediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Molecular Pharmaceutics 2012, 9, 2168-2179.
13. Ishida, T.; Harada, M.; Wang, X. Y.; Ichihara, M.; Irimura, K.; Kiwada, H. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. Journal of Controlled Release 2008, 105, 305-317.
14. Dams, E. T.; Laverman, P.; Oyen, W. J.; Storm, G.; Scherphof, G. L.; van der Meer, J. W.; Corstens, F. H.; Boerman, O. C. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. Journal of Pharmacology and Experimental Therapeutics 2000, 292, 1071-1079.
15. Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angewandte Chemie International Edition 2007, 46, 5754-5756.
16. Lundqvist, M.; Stigler, J.; Cedervall, T.; Elia, G.; Lynch, I.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Prceedings of the National Academy of Science of the United States of America 2008, 105, 14265-14270.
17. Lynch, I.; Dawson, K. A. Protein-nanoparticle interactions. Nano Today 2008, 3, 40-47.
18. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Baldelli Bombelli, F.; Dawson, K. A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. Journal of the American Chemical Society 2011, 133, 2525-2534.
19. Monopoli, M. P.; Baldelli Bombelli, F.; Dawson, K. A. Nanobiotechnology: nanoparticle coronas take shape. Nature Nanotechnology 2011, 6, 11-12.
20. Mahon, E.; Salvati, A.; Baldelli Bombelli, F.; Lynch, I.; Dawson, K. A. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery." Journal of Controlled Release 2012, 161, 164-174.
21. Walkey, C. D.; Olsen, J. B.; Guo, H.; Emili, A.; Chan, W. C. Nanoparticle size and surface chemistry determines serum protein adsorption and macrophage uptake. Journal of the American Chemical Society 2012, 134, 2139-2147.
22. Capriotti, A. L.; Caracciolo, G.; Caruso, G.; Foglia, P.; Pozzi, D.; Samperi, R.; Laganà, A. Differential analysis of "protein corona" profile adsorbed onto different nonviral gene delivery systems. Analytical Biochemistry 2011, 419, 180-189.
23. Capriotti, A. L.; Caracciolo, G.; Cavaliere, C.; Foglia, P.; Pozzi, D.; Samperi, R.; Laganà, A. Do plasma proteins distinguish between liposomes of varying charge density? Journal of Prosthodontics 2012, 75, 1924-1932.
24. Fleischer, C. C.; Payne, C. K. Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. Journal of Pharmacobio-Dynamics B 2012, 116, 8901-8907.
25. Dittrich, C.; Burckhardt, C. J.; Danuser, G. Delivery of membrane impermeable cargo into CHO cells by peptide nanoparticles targeted by a protein corona. Biomaterials 2012, 33, 2746-2753.
26. Caracciolo, G.; Pozzi, D.; Capriotti, A. L.; Cavaliere, C.; Cardarelli, F.; Bifone, A.; Bardi, G.; Salomone, F.; Laganà, A. Cancer cell targeting of lipid gene vectors by protein corona. Technical Proceedings of the 2012 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2012, 354-357.
27. Pande, P.; Mosleh, T. A.; Aust, A. E. Role of [α] V [β] 5 integrin receptor in endocytosis of crocidolite and its effect on intracellular glutathione levels in human lung epithelial (A549) cells. Toxicology and Applied Pharmacology 2006, 210, 70-77.
28. Deng, Z. J.; Liang, M.; Monteiro, M.; Toth, I.; Minchin, R. F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology 2011, 6, 39-44.
29. Prapainop, K.; Witter, D. P.; Wentworth, P. Jr. A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. Journal of the American Chemical Society 2012, 134, 4100-4103.
30. Lesniak, A.; Campbell, A.; Monopoli, M.; Lynch, I.; Salvati, A.; Dawson, K. A. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 2010, 36, 9511-9518.
31. Lundqvist, M.; Stigler, J.; Cedervall, T.; Berggård, T.; Flanagan, M. B.; Lynch, I.; Elia, G.; Dawson, K. The evolution of the protein corona around nanoparticles: a test study. Action (National Fund for Research into Crippling Diseases) 2011, 5, 7503-7509.
32. Pitek, A. S.; O'Connell, D.; Mahon, E.; Monopoli, M. P.; Baldelli Bombelli, F.; Dawson, K. A. Transferrin-coated nanoparticles: study of the bionano interface in human plasma. PLoS ONE 2012, 7, e40685.
33. Sandin, P.; Fitzpatrick, L. W.; Simpson, J. C.; Dawson, K. A. High-speed imaging of rab family small GTpases reveals rare events in nanoparticle trafficking in living cells. Action (National Fund for Research into Crippling Diseases) 2012, 6, 1513-1521.